Tuesday, June 24th, 2008.
With a latency period of 10-50 years, and with millions of Americans at risk for mesothelioma, an asbestos-generated cancer, the ravages of this life ending disease continue to disrupt families and lives. The Meso Foundation is hosting a press conference with leadership, members of Congress and three guest speakers who will share their poignant stories of loss due to mesothelioma.
The press conference will be held on the first day of the three-day 5th Annual International Symposium on Malignant Mesothelioma, sponsored by the Mesothelioma Applied Research Foundation (Meso Foundation), an event that offers information, support and awareness to help insure the banning of asbestos and increased dollars for meso research.
- Hyatt Regency Washington on Capitol Hill
The Lexington Conference Room, Ballroom Level
400 New Jersey Avenue N.W.
Washington, DC 20001
- Thursday, June 26, 2008
3:00 pm – 4:00 pm
- This press conference hosted by the Meso Foundation kicks off the first day of the three day International Symposium on Malignant Mesothelioma. The press conference is focused on the intergenerational impact of mesothelioma, with the three guest speakers: 12 year old, Lexi Miletto, whose grandfather died of meso in 2005; Taylor Stoeckler, 15 years old, whose father died of meso in 2007; and, Julie Gundlach, a young mother who has been diagnosed with meso.
- Asbestos is a known carcinogen, to which millions of Americans are unwittingly exposed each year. The damaging effects of asbestos do not manifest until decades after exposure — most often occurring as malignant mesothelioma. In the past eight years since the Meso Foundation has begun working on getting legislation passed, each year 3000 people have died of meso and tens of thousands have been exposed to asbestos. This press conference highlights the continued tragedy of meso and the desperate need for more research funding to help all those affected by this disease.
For more information or to arrange interviews with International Symposium on Malignant Mesothelioma participants, please contact Chris Hahn at (805) 252-8955 or Joel Schnur at (917) 647-2249 or email@example.com.
Speakers will be available for photo ops and interviews.
Program overview can be found at: http://www.marf.org/Documents/Sym07V2.pdf
Recent Posts in the Same Categories
Most Recent in Asbestos & Mesothelioma Studies
- Less Invasive Surgery Produces Longer Median Survival in Mesothelioma Patients
- Why Does Asbestos-Related Disease Continue to Rise?
- Targeted Immunotherapy Warrants More Research for Those Suffering from Pleural Mesothelioma
- Understanding the Signs and Symptoms of Asbestos Disease
- New Clinical Trial Underway for Immunotherapy Treatment; CA-170
Most Recent in Mesothelioma Applied Research Foundation (MARF)